Form 4 for TARA Protara Therapeutics, Inc.
Accepted 2026-01-21 00:00:00 ET · period of report 2026-01-16 · accession 0001213900-26-006230 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-01-21 | 2026-01-16 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +28.0K | 70.4K | +66% | $0 |
| D | 2026-01-21 | 2026-01-16 | TARA | Fabbio Patrick | CFO | A - Grant | $0.00 | +175.0K | 175.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-16 | A | A | 28,000 | $0.00 | 70,439 | D | — | — | (F1) The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of January 16, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-01-16 | A | A | 175,000 | $0.00 | 175,000 | D | $5.01 · — to 2036-01-15 | 175,000 Common Stock | (F2) 25% of the shares vest on the one year anniversary of January 16, 2026 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date. |